Cross-Sector entity
Science is most often covered alongside Alison Singer, which appears in 1 of these 2 stories. That works out to roughly 0.3 stories per week across a 41-day span. clinical-trial accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder.
2 verified stories tracked
Last mentioned: Sep 4, 2026
Entity pulse
Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Science is most often covered alongside Alison Singer, which appears in 1 of these 2 stories. That works out to roughly 0.3 stories per week across a 41-day span. clinical-trial accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. The tracked stories average 2 original sources each. This profile follows 2 Cross-Sector stories mentioning Science across the period from July 26, 2026 to September 4, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Science. Shared-story counts are live from our verified record — not editorial picks.
University investigation launched
Shanghai Jiao Tong University School of Medicine announces a special working group to investigate and promises 'serious action'.
Investigative report published
Science and Retraction Watch publish a joint exposé revealing the death and lack of disclosure, triggering international scrutiny.
Mei receives gene-editing therapy
Six-year-old girl with rare cognitive delay condition receives spinal infusion of trillions of engineered viruses in an experimental trial.
A UCSF team mapped more than 1,000 protein interactions tied to autism risk genes, creating a molecular atlas that could guide future drug development and precision diagnostics. The study, published in Science, moves autism research from single-gene findings toward systems-level biology, with implications for biomarker discovery and patient stratification.
Source: wyomingpublicmedia.org · iowapublicradio.org
The death of a young patient in a Chinese gene-editing trial, hidden from a subsequent Nature publication, sends shockwaves through the biotech sector. Industry leaders must grapple with the implications for gene therapy research integrity, funding, and the race to deliver transformative neurological treatments.
Source: channelnewsasia.com · straitstimes.com
